drug

TMS

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
DEVICE
Pre-approval / investigational in the US
Developed by Stanford University
3 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
DEVICE

Indications

Trials

3
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
NCT07290738—Recruiting
Brain Stimulation to the Hippocampus in Schizophrenia
NCT07010614—Recruiting
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
NCT04807530—Recruiting

KOLs & investigators

3
Xiaoming Du, PhDKOL score 5
Ethan A Solomon, MD, PhD
Karuna Subramaniam, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Stanford University
company
trial
Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders
NA
trial
Brain Stimulation to the Hippocampus in Schizophrenia
NA
trial
Medial-prefrontal Enhancement During Schizophrenia Systems Imaging
NA
trial
indication
Schizophrenia
indication
Schizophrenia Disorders
indication
Mental Disorder
indication
Schizophrenia Spectrum Disorder
indication
KOL
Xiaoming Du, PhD
KOL score 5
person
Ethan A Solomon, MD, PhD
KOL score —
person
Karuna Subramaniam, PhD
KOL score —
person